Literature DB >> 10905481

Metformin restores insulin secretion altered by chronic exposure to free fatty acids or high glucose: a direct metformin effect on pancreatic beta-cells.

G Patanè1, S Piro, A M Rabuazzo, M Anello, R Vigneri, F Purrello.   

Abstract

Because metformin affects glucose and free fatty acid (FFA) metabolism in peripheral insulin target tissues, we investigated the effect of this drug in restoring a normal secretory pattern in rat pancreatic islets whose function has been impaired by chronic exposure to elevated FFA or glucose concentrations. We cultured rat pancreatic islets with or without FFA (2 mmol/l oleate/palmitate 2:1) or high glucose (16.7 mmol/l) concentrations in the presence or absence of metformin (0.25-12.5 microg/ml) and then measured insulin release, glucose utilization, glucose, and FFA oxidation. When compared with control islets, islets exposed to high FFA or glucose concentrations showed an increased basal and a decreased glucose-induced insulin release. In islets cultured for an additional 24 h with FFA or glucose in the presence of metformin (2.5 microg/ml), both basal and glucose-induced insulin secretions were restored. Both glucose utilization and glucose oxidation were altered in islets pre-exposed to high FFA or glucose concentrations. In particular, regarding control islets, glucose utilization was increased at 2.8 mmol/l glucose and decreased at 16.7 mmol/l glucose; glucose oxidation was similar to control islets at 2.8 mmol/l glucose but decreased at 16.7 mmol/l glucose. In contrast, oleate oxidation was increased in islets pre-exposed to FFA. All of these abnormalities were reversed in islets cultured for an additional 24 h with high FFA or glucose concentrations in the presence of metformin (2.5 microg/ml). In conclusion, our data show that metformin is able to restore the intracellular abnormalities of glucose and FFA metabolism and to restore a normal secretory pattern in rat pancreatic islets whose secretory function has been impaired by chronic exposure to elevated FFA or glucose levels. These data raise the possibility that, in diabetic patients, metformin (in addition to its peripheral effects) may have a direct beneficial effect on the beta-cell secretory function.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10905481     DOI: 10.2337/diabetes.49.5.735

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  38 in total

1.  Effects of metformin on oxidative stress, adenine nucleotides balance, and glucose-induced insulin release impaired by chronic free fatty acids exposure in rat pancreatic islets.

Authors:  S Piro; A M Rabuazzo; M Renis; F Purrello
Journal:  J Endocrinol Invest       Date:  2011-07-12       Impact factor: 4.256

Review 2.  Small-molecule inhibition of inflammatory β-cell death.

Authors:  M Lundh; S S Scully; T Mandrup-Poulsen; B K Wagner
Journal:  Diabetes Obes Metab       Date:  2013-09       Impact factor: 6.577

3.  High Recovery of Functional Islets Stored at Low and Ultralow Temperatures.

Authors:  Bhawna Chandravanshi; Anandh Dhanushkodi; Ramesh Bhonde
Journal:  Rev Diabet Stud       Date:  2015-02-10

4.  Short-term treatment with metformin reduces hepatic lipid accumulation but induces liver inflammation in obese mice.

Authors:  Alexandre Abilio de Souza Teixeira; Camila O Souza; Luana A Biondo; Loreana Sanches Silveira; Edson A Lima; Helena A Batatinha; Adriane Pereira Araujo; Michele Joana Alves; Sandro Massao Hirabara; Rui Curi; José Cesar Rosa Neto
Journal:  Inflammopharmacology       Date:  2018-02-15       Impact factor: 4.473

5.  Mitochondrial Proton Leak Regulated by Cyclophilin D Elevates Insulin Secretion in Islets at Nonstimulatory Glucose Levels.

Authors:  Evan P Taddeo; Nour Alsabeeh; Siyouneh Baghdasarian; Jakob D Wikstrom; Eleni Ritou; Samuel Sereda; Karel Erion; Jin Li; Linsey Stiles; Muhamad Abdulla; Zachary Swanson; Joshua J Wilhelm; Melena D Bellin; Richard G Kibbey; Marc Liesa; Orian S Shirihai
Journal:  Diabetes       Date:  2019-11-18       Impact factor: 9.461

Review 6.  Metformin: new understandings, new uses.

Authors:  Ripudaman S Hundal; Silvio E Inzucchi
Journal:  Drugs       Date:  2003       Impact factor: 9.546

7.  Pharmacogenetics of Anti-Diabetes Drugs.

Authors:  Johanna K Distefano; Richard M Watanabe
Journal:  Pharmaceuticals (Basel)       Date:  2010-08-01

Review 8.  Interventions to preserve beta-cell function in the management and prevention of type 2 diabetes.

Authors:  Kathleen A Page; Tamar Reisman
Journal:  Curr Diab Rep       Date:  2013-04       Impact factor: 4.810

Review 9.  Therapeutic Concentrations of Metformin: A Systematic Review.

Authors:  Farshad Kajbaf; Marc E De Broe; Jean-Daniel Lalau
Journal:  Clin Pharmacokinet       Date:  2016-04       Impact factor: 6.447

10.  Effects of rosiglitazone and metformin on pancreatic beta cell gene expression.

Authors:  H Richardson; S C Campbell; S A Smith; W M Macfarlane
Journal:  Diabetologia       Date:  2006-02-18       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.